Interventions to improve patients’ compliance with therapies aimed at lowering glycated hemoglobin (HbA1c) in type 1 diabetes: systematic review and meta-analyses of randomized controlled clinical trials of psychological, telecare, and educational interventions

Table 1 Mean glycated hemoglobin (HbA1c) and percentage of patients with type 1 diabetes who are on glycemic target in Brazilian centers

Author	Number	Region of Brazil	HbA1c (%)	Percentage of patients on glycemic target*
Author	Number	Region of Brazil	(mean ± SD)	Percentage of patients on glycemic target*
Rodrigues et al. 2010 [10]^a	573	South	9.0 ± 3.9	22.0 %
Mendes et al. 2010 [49]^b	979	South, Southeast, Northeast, Middle-west	-	7.0 %
Gomes et al. 2012 [50]^c	3591	South, Southeast, North/Northeast, Middle-west	9.1 ± 2.3 to 9.4 ± 2.6	12.2 to 21.4 %
Gomes et al. 2012 [51]^d	1774	South, Southeast, North/Northeast, Middle-west	9.1 ± 2.2	11.6 %
Viana et al. 2013 [52]^e	1026	South, Southeast, North/Northeast, Middle-west	9.3 ± 2.3	13.0 %

*Glycemic targets: ^{a, b, e}HbA1c <7.0 %; ^{c, d}HbA1c <7 % – adults, HbA1c <7.5 % – 13 to 19 years, HbA1c < 8 % – 6 to 12 years, HbA1c >7.5 % and HbA1c <8.5 % – < 6 years

ISSN: 1745-6215